The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Article Type
Changed
Thu, 01/10/2019 - 12:05
Display Headline
The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle

Article PDF
Author and Disclosure Information

Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M, for the Adapalene Study Group

Issue
Cutis - 76(2)
Publications
Topics
Page Number
145-151
Sections
Author and Disclosure Information

Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M, for the Adapalene Study Group

Author and Disclosure Information

Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M, for the Adapalene Study Group

Article PDF
Article PDF

Issue
Cutis - 76(2)
Issue
Cutis - 76(2)
Page Number
145-151
Page Number
145-151
Publications
Publications
Topics
Article Type
Display Headline
The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle
Display Headline
The Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Acne Vulgaris: A Randomized, Multicenter, Investigator-Blinded, Controlled Comparison Study Versus Adapalene Gel 0.1% and Vehicle
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Article Type
Changed
Thu, 01/10/2019 - 12:00
Display Headline
Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis

Article PDF
Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Issue
Cutis - 73(1)
Publications
Topics
Page Number
31-38
Sections
Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Author and Disclosure Information

Donald V. Belsito, MD; Joseph F. Fowler, Jr, MD; James G. Marks, Jr, MD; David M. Pariser, MD; Jon Hanifin, MD; Ida Alzira Gomes Duarte, MD; Mario C. Pires, MD; Ponciano D. Cruz, Jr, MD; Richard G.B. Langley, MD; Premal Patel, BS; Christopher Bush, PhD; Mark Thurston, MSc; Michael Graeber, MD; Robert Cherill, MS; and the Multicenter Investigator Group

Article PDF
Article PDF

Issue
Cutis - 73(1)
Issue
Cutis - 73(1)
Page Number
31-38
Page Number
31-38
Publications
Publications
Topics
Article Type
Display Headline
Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis
Display Headline
Pimecrolimus Cream 1%: A Potential New Treatment for Chronic Hand Dematitis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media